Loïc Lefebvre

Title: Loïc Lefebvre: Innovator in Pharmaceutical Chemistry

Introduction

Loïc Lefebvre is a notable inventor based in Mont Saint Aignan, France. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of innovative medicinal products. With a focus on improving drug formulations, Lefebvre has been awarded a total of 2 patents for his groundbreaking work.

Latest Patents

Lefebvre's latest patents include the following:

1. **β Crystalline form of the arginine salt of perindopril** - This patent describes a process for its preparation and pharmaceutical compositions containing it. The β-crystalline form of the compound is characterized by its powder X-ray diffraction diagram and is useful as an inhibitor of angiotensin I converting enzyme.

2. **α Crystalline form of the arginine salt of perindopril** - Similar to the previous patent, this invention outlines a process for its preparation and pharmaceutical compositions. The α-crystalline form is also characterized by its powder X-ray diffraction diagram and serves as an inhibitor of angiotensin I converting enzyme.

Career Highlights

Lefebvre is currently associated with Les Laboratoires Servier, a prominent pharmaceutical company known for its commitment to research and development. His work at Servier has allowed him to focus on innovative solutions that enhance the efficacy of medications.

Collaborations

Throughout his career, Lefebvre has collaborated with esteemed colleagues such as Gérard Coquerel and Jean-Claude J. Souvie. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and advancements in pharmaceutical research.

Conclusion

Loïc Lefebvre's contributions to pharmaceutical chemistry through his patents and collaborations highlight his dedication to innovation in the field. His work continues to impact the development of effective medicinal products that benefit patients worldwide.